Meet the 25 Year-Old Behind L.A.'s Plan to Test Every Resident for COVID-19

Rachel Uranga

Rachel Uranga is dot.LA's Managing Editor, News. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines.

Meet the 25 Year-Old Behind L.A.'s Plan to Test Every Resident for COVID-19

Fred Turner, the 25-year-old founder of Curative Inc., is the man behind L.A.'s push to bring universal testing to the region. But, he has bigger plans.

Turner, an Oxford dropout, just landed a deal with the Air Force to test military worldwide and he's now eyeing national expansion for his startup. By the end of this month, the company he started months ago is expected to pump out more than a million test kits a week.

"We are a strange company because our goal is to essentially put ourselves out of business," Turner said.


Turner, who was named UK Young Engineer of the Year at age 17 when he built a DNA machine from his bedroom to figure out why his brother had red hair and he had brown hair, turned his focus to coronavirus in January. He upended his life as head of Shield Bio, which sought to eliminate sepsis, and moved to Southern California after a local venture capitalist connected him with a lab that he could build out for COVID-19 testing.

Curative Inc. was born.

Curative, Inc. Founder Fred Turner is the man behind L.A.'s push to bring universal testing to the region.

For weeks he lived in hotels as he created what has become the backbone of testing in America's second largest city. The company, one of the few saliva-based tests that have gotten emergency approvals from the FDA, has a 10% false negative rate, according to their own non-peer reviewed studies. Turner argues the rate is better than most of the nasal swab testing out there and oral tests, which can be self-administered, are the only way the country can reopen quickly.

He is now operating two labs, one in San Dimas another in Washington D.C., with plans for several more across the nation. Meanwhile, the rest of the country is watching to see if Los Angeles' promise of universal testing meets the expectations with some already complaining about the difficulty of securing an appointment.

dot.LA: Curative is responsible for 95% of Los Angeles COVID-19 tests. Can you meet the demand for universal testing?

Curative, Inc. Founder Fred Turner: We will be able to fulfill demand. There's more infrastructure that needs to be put in place. With the collection site, the mayor's office has been working hard to scale those up and make sure that the collection site infrastructure is in place. On the lab side, we definitely have enough capacity to serve the area.

In (the San Dimas) lab we have capacity for about 20,000 per day. We're going to be scaling this lab up to 30,000 over the next week or so, eventually, probably slightly more than that.

Ultimately, the goal is to do as many tests as we need to reopen the country and I think we've had many different estimates of how many that might be. I've heard estimates (that it will take) as high as five million tests a day to reopen, but the current supply chain is nowhere near going to be able to keep up with that. The next goal we are shooting for is a million tests a week by about mid-May, end of May.

If we're testing more people will that strain the turnaround time? Right now, I understand it's about 24 to 72 hours. Can you take it down to several hours or even minutes?

We are always aiming to push it down. I think it can be pushed under 24 hours, but we tend to focus more on scaling it up at that point. I think 24 hours is around optimal as you bring on more capacity. We're obviously being careful to match the capacity coming into the lab against the turnaround.

Curative is one of the few companies that the FDA has provided emergency approval for use of a saliva test. Do you think this is the answer to universal testing nationally? 

Oral fluids is the technical term, which is slightly different from saliva. Our protocol involves having the person cough first, which releases virus from the upper and lower respiratory tract. Some of that is then caught in the saliva, and also viruses in the saliva. The idea is you're effectively sampling multiple sites at once, which we think gives a slight increase in the sensitivity of the testing.

Self-collected sampling has got to be the way forward. There's just no way that we can do a million nasal pharyngeal swabs, or we call them 'brain swabs,' it's just not practical. We don't have the medical staff, and as a country we just can't do that many swabs. And so the way forward is going to be self collection. That's the only thing we can do at scale.

Covid-19 Oral Fluid Test Kit Instructionswww.youtube.com

Curative recently secured a contract with the Department of Defense. What's next?

We haven't settled on the exact number, but we will be in a large number of states. That is the plan, building out the infrastructure for this kind of testing. We can take the L.A. model and scale it across the country. We have a version of the drive-thru software that other cities and states can take. We have all the training material. We have a team that fly around the country setting up these drive-thru sites. We have really tried to make a plug-and-play package where cities and states that want to launch drive-thru testing, we have everything they need.

Is Los Angeles a testing ground and a proving ground for national efforts?

Yeah, I think Mayor Garcetti has definitely demonstrated what can be done if the city moves very quickly to build out the infrastructure, I do think the drive-thru testing, walk through testing is going to be an essential component of this.

It's just much faster to get the samples to the lab than shipping it out and then shipping it back again. The infrastructure piece is critical for getting these tests out there and we're working with several other states now on building out a similar infrastructure. Some of them have existing programs that we would be plugging into and expanding, and some of them are looking to roll out their own similar programs. You can test a lot more people with the oral tests with far fewer staff.

What are the challenges with the supply chain in terms of making your tests more widely available?

We need more plastic, more robots, more people. Most of the components that go into these tests are just already maxed out in their production capacity. And so we've been throwing online a bunch of internal production, such as injection molding to make our swab kit tubes, as well as bringing on other sources of similar materials that are not being used for COVID-19 testing and validating them for COVID. So for the swabs, for example, we use a swab type that is usually used for testing clean rooms. It works just as well for COVID testing, but nobody else is using it for that purpose.

We don't want to be competing with other people, stopping them from getting access to resources. We want to bring on new supply so it's not a zero- sum game, and the total amount of tests will increase. But, I think distribution is going to be a bigger bottleneck over the next month. Los Angeles has done a fantastic job in building out infrastructure and collection. That needs to happen now across the whole country.

What would it take to meet national demand?

It would take a network of multiple labs that we are calling gigalabs that can process 50,000 to 100,000 tests a day across the country and a significant scale up in the production of the physical components that go into the tests. We've been investigating lab sites in a few states, something central like Texas or Colorado.

Are you concerned that you have too high of a false negative rate at 10%?

All COVID tests will have false negative rates. In our studies, we demonstrated that the sensitivity is at least as good if not better than the nasal pharyngeal swab tests. So, there will definitely be false negatives as there will be in every test, but we think the data supports us having a low rate of false negatives. The sensitivity is about 90%.

When you include all patients, the nasal pharyngeal came in at about 79%. A new (non-peer reviewed) Yale study shows a higher sensitivity from saliva and all fluids than the nasal pharyngeal. I don't think we have the evidence to say that we're better yet, but we have the evidence to say that we're at least equivalent. The ease of doing oral tests and the accessibility is obviously significantly better. We're not using PPE. We're not exposing healthcare workers. It's just a much easier test to roll out that people can test themselves.

File:Florida National Guard (49677710741).jpg - Wikimedia Commonsupload.wikimedia.org

At one point, Curative was attempting to roll out at-home testing and then had to pull back after FDA warnings. Will you be making home testing kits again?

I can't give a time estimate but we are actively working with the FDA right now. I think their concern is "can people adequately collect the sample, or will they do it wrong, and then get a negative test result," which is incorrect. Our plan is to use telemedicine observation. What we've seen in our clinical studies is that if you give people the chance to do it wrong, they will do it wrong. In fact when you have somebody observing, they read the instructions better and they collect a better sample. We're still working on the pricing and potentially looking at whether there is federal or state reimbursement for some of that testing and the potential of billing insurance.

Tracing technology has been promising. Do you have any plans to tie tests to these applications to testing? 

We've had several conversations with contact tracing apps and we continue to work in collaboration with public health departments in their contract tracing efforts. Having the test is obviously one thing, but you have to use the information to actually stem the tide of COVID infection. And so, it is an essential step in working closely with various people.

I do like the app-based models where you obviously want to maintain people's privacy, but having people opt-in to share their location history if they test positive so you can contact nearby people.

What does Curative do once there's a vaccine? Are you obsolete?

The U.S. needs to maintain some kind of spare capacity so that next time we are not having to build all of this during a pandemic. But we are a strange company because our goal is to essentially put ourselves out of business. Ultimately, and I say this to everyone we hire, we don't know how long this will go on for. We want to provide as many tests as needed, but the goal is to end COVID and not be doing COVID testing anymore.

Curative took off in March when you arrived in Los Angeles from Silicon Valley, how has the journey been for you personally?

I don't have very much free time, but it's been a lot of fun to be able to work at this pace and have the support of people like the city, the mayor's office to really just do what is needed to scale this up. When we work with suppliers, and we say we're doing COVID testing, they just move heaven and earth to make things happen. It's been really inspiring to be a part of that push forward.

We are just pushing as hard as we can to scale up as fast as we possibly can and bring on as much testing as we can. The city opening up testing to everybody is kind of a culmination of that. We're making about 50,000 kits a day right now and we want to make that as widely available as we can. I would like to get a little more sleep.

The interview has been edited for clarity and brevity.

Correction: An earlier version of this story stated that Curative's saliva tests have a 10% false positive rate. In actuality, the tests have a 10% false negative rate.

Do you have a story that needs to be told? My DMs are open on Twitter @racheluranga. You can also email me.

From Your Site Articles
Related Articles Around the Web
https://twitter.com/racheluranga
rachel@dot.la
From Sunset Boulevard to Outer Space: LA’s Latest

🔦 Spotlight

Good Morning Beliebers and Los Angeles!

While Justin Bieber’s new album dropped last night, here’s what else is making headlines in Los Angeles this week.

Luma has opened its Dream Lab on Sunset Boulevard, boldly positioning itself at the forefront of AI-powered creativity. Known for transforming ordinary photos into cinematic 3D scenes, Luma is combining cutting-edge research with practical tools to build a playground for artists, engineers, and anyone ready to push the boundaries of visual storytelling. In their words: “From Hollywood blockbusters to the next generation of immersive media, this is where the magic happens.”

Meanwhile, well beyond our skyline, SpaceX reportedly hit an eye-popping $400 billion valuation in a recent share sale, making it one of the most valuable private companies ever. The milestone reflects both investors’ fervor for the commercial space race and LA’s unrivaled role as the launchpad of aerospace innovation.

LA continues to prove it can deliver on the ground, in the cloud, and far beyond the stars. See you next week.

🤝 Venture Deals

LA Companies

     
  • Varda Space Industries, the El Segundo–based company manufacturing pharmaceuticals in microgravity, has raised $187M in a Series C round led by Natural Capital and Shrug Capital, bringing its total funding to approximately $329M. The funds will support an increased launch cadence of robotic drug-production capsules, expansion of its El Segundo lab for biologic drug crystallization, and broader efforts to scale commercial microgravity-driven drug formulation and hypersonic reentry testing. - learn more

LA Venture Funds

  • Rebel Fund participated in Vellum’s $20M Series A round, which was led by Leaders Fund. The company helps businesses build and optimize LLM-powered applications. Vellum plans to grow its team and speed up product development with the new funding. - learn more
  • Bold Capital participated in a $31M Series B funding round for Aqtual, a Hayward, California based precision medicine startup developing a cutting edge cell free DNA (cfDNA) multiomics platform. The capital will help commercialize Aqtual’s flagship rheumatoid arthritis diagnostic, currently being tested in a 1,300 patient trial, and support expansion into other chronic and autoimmune diseases. - learn more
  • Strong Ventures invested in VERAMORE, a skincare brand focused on addressing early signs of aging in women. Since launching in March 2022, VERAMORE has grown over 300% annually, expanded to more than 16 products, and entered markets including Japan, Singapore, Vietnam, Taiwan, Europe, and Korea. The funding will support its D2C growth, product-driven marketing, and planned global expansion starting with Japan in 2025 and the U.S. and Europe in 2026. - learn more
  • Mucker Capital joined a $3.7M seed funding round for Velvet Capital aimed at launching its DeFAI operating system and $VELVET governance token. Velvet’s vertically integrated DeFi toolkit combines AI-powered trading, portfolio management, APIs, and a native token to streamline on-chain investment for funds, DAOs, and individual traders. The funding will accelerate platform development, the rollout of its tokenomics, and broader adoption of its intent-based DeFi suite. - learn more
  • Btech Consortium Fund participated in a $8.5M Series A funding round for Castellum.AI, a New York based financial crime compliance platform that uses in‑house risk data, AI, and screening tools to help financial institutions manage AML/KYC compliance. The funds will be used to expand their team, enhance integrations with financial institutions, and accelerate adoption of their AI‑powered compliance solutions. - learn more
  • Bold Capital Partners joined the oversubscribed $45M Series A round for Centivax, a South San Francisco biotech company dedicated to developing a universal flu vaccine using a proprietary mRNA-based immune-engineering platform. Led by Future Ventures, the funding will help Centivax advance its lead candidate into Phase I clinical trials and expand its broader universal immunity pipeline targeting pathogens like RSV, HIV, and malaria. - learn more
  • Alpha Edison participated in Honor Education’s $38M Series A funding round for the San Francisco–based learning platform. Honor uses AI‑enhanced, mobile-first courses and credentialed programs to improve engagement and leadership development. The funding will be used to scale AI capabilities, personalize learning experiences, and expand the company’s operations and customer‑success teams to meet rising demand. - learn more
  • Wasserman Ventures participated in a $7M seed round for Fantasy Life, the fantasy sports platform founded by Matthew Berry. The funding will support the launch of Fantasy Life’s revamped platform, featuring new “Guillotine Leagues,” a modernized app experience, and enhanced content and tools to scale its audience and technology offerings. - learn more

LA Exits
  • El Segundo based Kaye Capital Management, a fee only RIA with approximately $700M in assets under management and $300M in assets under advisement, was acquired by Modern Wealth Management, marking its 17th acquisition and pushing its total AUM over $8.5B. The deal strengthens Modern Wealth’s presence in California and adds Kaye’s institutional retirement plan expertise to its suite of financial and retirement solutions for clients. - learn more
  • NIRx Medical Technologies was acquired by Gilde Healthcare’s private equity fund and combined with Artinis Medical Systems to form a world-leading neuroimaging group. Both companies will retain their brands and locations while collaborating on R&D, product development, and global expansion of their functional near-infrared spectroscopy (fNIRS) tools to advance research in mental health, neurodegenerative diseases, and stroke rehabilitation. - learn more
  • Emotive, a conversational SMS marketing platform, has been acquired by Privy to create a unified solution for e-commerce brands that combines email, SMS, pop-ups, and real-time customer conversations. The integrated platform will help over 10,000 merchants simplify their marketing, personalize customer interactions, and strengthen relationships with dedicated strategists and transparent pricing. - learn more

Download the dot.LA App

Tinder, Starlink, and Apple’s New Studio: This Week in LA

🔦 Spotlight

Happy Independence Day, Los Angeles! 🇺🇸

While you're celebrating freedom, here are some electrifying updates lighting up LA’s tech, satellite, and music scenes:

🔥 Tinder mandates Face Recognition in California

  Image Source: Tinder

Tinder is now requiring all new users in California to complete a biometric face check, a brief video selfie processed via FaceTec, to verify profiles are genuine. The video is deleted post-verification, though an encrypted face map remains while the account is active. This West Hollywood based move could redefine trust, safety, and privacy in mainstream consumer apps.

🌐 Starlink clears hurdle to launch in India

Elon Musk’s SpaceX backed Starlink has cleared most regulatory and licensing hurdles with India’s Department of Telecommunications, marking a key step toward launching satellite broadband in one of the world’s fastest growing markets. Final approvals from the national space regulator are pending, and services, expected to deliver high speed connectivity to underserved regions, could launch in the coming months. This is a major milestone for Starlink’s global expansion.

🎧 Apple Music opens Culver City creative hub

  Image Source: Apple

Apple Music is celebrating its anniversary by launching a brand new 15,000 square foot, three story studio in Culver City. The facility, featuring a 4,000 square foot soundstage, spatial audio suites, podcast booths, and more, is designed by Eric Owen Moss and slated to open mid August. It solidifies LA’s reputation as a creative powerhouse and reaffirms Apple’s commitment to investing in and nurturing our city's cultural ecosystem.

From dating apps to deep space to sound stages, LA isn’t just watching the future unfold, we’re building it.

Here’s to independence, imagination, and everything this city dares to launch next. Happy Fourth, Los Angeles.

🤝 Venture Deals

LA Companies

  • Castelion has raised a $350M Series B round led by Lightspeed Venture Partners alongside Altimeter Capital to scale its hypersonic missile production capabilities. The El Segundo-based defense startup plans to use the funds to expand manufacturing, accelerate testing through its SpaceX-inspired rapid development model, and position itself as a cost-effective supplier of hypersonic weapons to the U.S. military and its allies. - learn more
  • Earth Sama, a Calabasas, California–based climate-tech platform that helps rural farming and Indigenous communities generate and manage carbon credits, secured investment from Omtse Ventures. The funding will support the rollout of Earth Sama’s blockchain-powered field app, climate-creator platform, and smart-contract tools to scale community-led carbon credit projects globally under the Paris Agreement’s Article 6.4 framework. - learn more

            LA Venture Funds

            • Plassa Capital participated in Metafide’s $3.275M funding round. Miami based Metafide, the creator of SURGE, a gamified trading platform that combines AI neural networks and human insight, will use the funds to scale and launch SURGE into the market. - learn more
            • BOLD Capital Partners participated as a founding investor in Syntis Bio’s $33M Series A round, with an additional $5M in NIH grants. The Boston-based biotech is developing oral therapies for obesity and rare diseases, and the funding will help advance its SYNT platform, moving its lead obesity treatment, SYNT-101, into Phase 1 trials and supporting development of SYNT-202 for homocystinuria. - learn more
            • BAM Ventures participated in Cred’s $15M seed round for its predictive intelligence startup. San Francisco based Cred uses AI to unify company data with real time market signals and deliver actionable insights for sales and operations. The funding, led by defy.vc, will be used to scale Cred’s platform, expand its customer base, and grow team and product capabilities. - learn more
            • BOLD Capital Partners participated in Gallant’s $18M Series B round to advance its ready-to-use stem cell therapies for pets. The funding, led by Digitalis Ventures with additional support from NovaQuest Capital, will help Gallant bring its off-the-shelf regenerative treatments to market. - learn more
            • Rebel Fund joined the seed round for Rocketable, contributing to the $6.5M raised to build a portfolio of fully automated SaaS companies. San Francisco-based Rocketable, backed by True Ventures and others, uses AI agents to operate acquired software products, and Rebel’s support will help scale both the platform and acquisitions. - learn more 
                    LA Exits
                    • Leasepath, a cloud-first provider of equipment lease and loan management software, has been acquired by Solifi to enhance its mid-market offerings. The deal allows Solifi to expand Leasepath’s Microsoft Dynamics-based platform into new global markets while keeping Leasepath’s team and leadership in place. - learn more

                              Download the dot.LA App

                              Senra Raises $25M to Rewire LA's Aerospace Supply Chain

                              🔦 Spotlight

                              Hello Los Angeles,

                              In the shadow of LA’s booming space and defense scene, a new kind of hardware startup is scaling up. And it's not building flying cars or flashy robots. It’s building the infrastructure that builds everything else.

                              This week, Senra Systems announced a $25 million Series A led by Dylan Field and CIV, with participation from General Catalyst, Sequoia Capital, Founders Fund, Andreessen Horowitz, 8VC, and Pax Ventures. Their Redondo Beach-based facility is using custom automation, software, and new design tools to quadruple production speed. The goal is to solve a notoriously manual, bottleneck-prone part of the supply chain: wire harness manufacturing.

                              The company also launched Amp, a CAD software platform that bridges the gap between harness design and physical production. It's a process that has historically been slow, fragmented, and hard to scale. In other words, Senra isn’t just building machines. They’re rewiring the very systems that power aerospace, defense, and industrial tech.

                              It’s not sci-fi. It’s supply chain innovation. And it’s very LA.

                              Catch the latest LA venture deals, acquisitions, and fund updates below.

                              🤝 Venture Deals

                              LA Companies

                              • 2wai, co-founded by actor Calum Worthy and producer Russell Geyser, has emerged from stealth with the launch of its avatar-based social app, allowing users to create lifelike “HoloAvatars” in under three minutes for real-time, multi-language conversations. The platform gives individuals, especially creators and entertainers, control over their digital likeness by restricting avatar responses to pre-approved information, helping counter deepfake threats. The launch follows a $5 million pre-seed raise and sets the stage for broader use by celebrities, brands, and educational partners. - learn more
                              • Superfiliate secured a $2M strategic growth round led by HappyStack to fuel its rapid expansion in the creator commerce space. The platform, which automates influencer and affiliate marketing for CPG and DTC brands via deep Meta and TikTok integrations, has achieved an impressive 400% year-over-year growth. The investment will support scaling its automation engine, deepening social commerce partnerships, and onboarding more e-commerce brands. - learn more
                              • Gemist, a Los Angeles–based jewelry-tech startup, secured $6M in seed funding from Entrada Ventures, Artemis Fund, and Collide Capital, bringing its total funding to $9M. The platform offers real-time 3D visualizations, dynamic pricing, and integrated e-commerce for custom fine jewelry, and is used weekly by over 14,000 customers to design personalized pieces. The new capital will enhance its visualization tools, pricing engine, and commerce features as Gemist expands its footprint. - learn more
                              • Chronicle Studios has raised an oversubscribed $11.6M seed round co-led by Patron and Point72 Ventures to fuel the development of original, audience-driven franchises. Founded by former DreamWorks and Warner Bros. exec Chris deFaria and tech entrepreneur Aaron Sisto, the LA-based studio plans to invest in independent creators and build AI-powered tools, like automated YouTube thumbnails and social analytics, to help storytellers grow and monetize their IP. - learn more
                              • Stackup, a developer platform for crypto applications, has raised a $4.2M in seed funding round led by 1kx. Stackup helps crypto businesses build better user experiences and manage on-chain user data, and the funding will be used to grow its engineering team and expand support for more blockchain networks. - learn more
                              • Doên, a fashion brand known for its vintage-inspired, California aesthetic, has closed a growth equity round led by Silas Capital. The funding will help the company expand its retail footprint, grow its team, and scale operations. Doên plans to continue building its community-driven brand while deepening its commitment to sustainability and women's empowerment. - learn more
                              • Root has raised a $9M seed funding round led by Konvoy and Headline, to develop its platform for managing online communities. The app, currently in closed beta, enables users to build custom tools like raid planners and task trackers right into their social experience. The fresh capital will fuel team expansion and product development ahead of a broader rollout. - learn more
                              • AndrenaM, a defense-tech startup founded by a former SpaceX engineer, raised $10M in just 36 hours. The company is building an AI-powered maritime sensing network using sonar-equipped buoys to provide real-time underwater surveillance. The funding, led by First Round Capital, will support team expansion, custom hardware development, and scaled deployments off the California coast. - learn more

                                      LA Venture Funds

                                      • Westlake Village BioPartners joined Neuron23’s $96.5M Series D financing round. The capital will fund the global Phase 2 NEULARK trial of NEU‑41, a brain-penetrant LRRK2 inhibitor for early-stage Parkinson’s disease, as well as support commercial and R&D scale-up. Neuron23 also announced that the first patient has been dosed in the NEULARK study, with initial results expected in 2027. - learn more
                                      • Fika Ventures participated in Spinwheel’s recent $30 M Series A round led by F‑Prime Capital. The funds will be used to accelerate their AI-powered platform that streamlines debt and credit management, reducing friction in account authentication, automating payments, and integrating liability data, all to deliver instant, developer-friendly credit APIs. This investment supports rapid growth across fintech and banking partners aiming to improve consumer credit outcomes. - learn more
                                      • Chaac Ventures participated in a $7M seed funding round for Meridian, a New York and Miami‑based startup using its AI-powered deal management platform to help private equity firms streamline sourcing, automate workflows, and improve diligence efficiency. The funding will accelerate product enhancements, expand the global go‑to‑market strategy, and deepen its traction with large institutional investors. - learn more
                                      • WME joined a debut funding round for haircare disruptor isima, which raised over $12M to accelerate its launch. Shakira-backed and science-driven, isima will use the capital to scale operations, expand product development, and roll out via isima.com and placements at Ulta Beauty (U.S. in July; Mexico in August), debuting across nearly 30 global markets. - learn more
                                      • M13 participated in Maven AGI’s Series B round, which raised $50M to expand its Business AGI platform for enterprise use. The funding brings Maven’s total capital raised to $78M. The company will use the investment to accelerate product development and go-to-market efforts as it scales its AI platform that unifies customer journeys across support, sales, and operations. - learn more
                                      • Alexandria Venture Investments joined GeneCentric Therapeutics’ $8M Series C round. The funding will support the commercial launch of GenomicsNext™, a groundbreaking liquid biopsy platform that combines extensive gene expression profiling with high‑fidelity DNA variant detection from ctDNA. This capital is expected to carry GeneCentric through 2026 and to help it scale predictive biomarker development for oncology applications. - learn more
                                      • MTech Capital and B Capital participated in COVR Global’s $2.5M seed round, led by MTech Capital. The funding will help COVR develop its AI-powered Decision Engine—a modular platform that enables insurers to make instant, data-driven claims decisions, such as coverage validation, liability assessment, and settlement automation. The investment will fuel product development and team growth as COVR scales across the UK, Spain, Japan, and Australia - learn more
                                      • Bedrock and Khosla Ventures co-led Mach Industries’ $100M Series B round. The defense-tech startup will use the capital to ramp up production at its Forge Huntington factory, grow its Mach Propulsion engine division, and further develop and deploy its advanced unmanned systems—Viper, Glide, and Stratos. This funding brings Mach’s total raised to about $185M as it scales vertically integrated defense manufacturing. - learn more
                                      • Fifth Wall participated in Juniper Square’s Series D funding round, which secured $130M at a $1.1 billion valuation. The investment will be used to accelerate the development and deployment of JunieAI, an AI-powered, agentic platform tailored specifically for private markets general partners to streamline investor relations, reporting, and fund administration. - learn more
                                      • Mucker Capital led CarePilot’s $2.5M seed round, with participation from KCRise Fund. The Overland Park-based startup will use the funding to further develop its AI-powered tools including its new “ProblemAssist” diagnostic and coding tool and expand its team as it scales solutions for healthcare providers. - learn more
                                      • Prototype Capital participated in Sunrise Robotics’ seed round, which raised $8.5M to emerge from stealth and advance its factory automation technology. The Ljubljana-based startup develops dual‑arm robotic cells trained in simulated environments, enabling rapid, cost-effective deployment and continuous learning across a fleet. The funds will be used to scale AI and simulation capabilities, expand team and manufacturing across Europe, and deepen customer deployments in sectors like electronics, supercars, and battery production. - learn more
                                            LA Exits
                                            • Comco, the pioneer behind the MicroBlaster® micro-precision sandblasting system, has been acquired by Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management. This strategic move integrates Comco’s advanced abrasive technology into MMT’s suite, expanding its capabilities in precision microblasting for medical, aerospace, microelectronics, and industrial applications. MMT CEO Robbie Atkinson emphasized that the acquisition strengthens their end-to-end manufacturing offerings, while Comco President Colin Weightman joins MMT to drive continued innovation and customer growth. - learn more
                                            • 3BlackDot, the creator-first gaming and digital media studio known for popular YouTube franchises like Gaming While Black and Alpha Betas, has been acquired by Offscript Worldwide, the parent company of Revolt. With an audience of over 128 million subscribers, the acquisition marks Offscript’s entry into the $347 billion gaming industry and strengthens its creator-led IP development and distribution capabilities. 3BlackDot will now leverage Offscript’s infrastructure to scale its cultural impact while maintaining its creator-first approach. - learn more
                                            • Dr. Squatch, the fast-growing natural men’s grooming brand known for its social-first marketing and strong DTC presence, is being acquired by Unilever from Summit Partners. The move gives Unilever access to a brand with viral campaigns, influencer collaborations, and revenues reportedly around $400M, enhancing its premium personal care offerings. The deal is expected to close later this year pending regulatory approvals. - learn more
                                            • CloudSoda has been acquired by Diskover Data, combining CloudSoda’s intuitive data orchestration and automation with Diskover’s enterprise-scale indexing, metadata enrichment, and AI-ready infrastructure. This comes alongside Diskover’s $7.5M seed round, led by Snowflake Ventures and NetApp, positioning the company to accelerate unified, intelligent management of unstructured data. - learn more
                                            • Inspire Clean Energy has been acquired by Rhythm Energy, significantly expanding Inspire’s reach beyond its original markets. The merger creates one of the largest independent green energy retailers in the U.S., combining Inspire’s subscription-based, 100% renewable electricity plans with Rhythm’s technology-driven platform. This union positions the combined company to serve millions more customers nationwide, offering enhanced digital tools, demand-response programs, and time-of-use pricing to promote clean energy adoption. - learn more

                                                    Download the dot.LA App

                                                    RELATEDEDITOR'S PICKS
                                                    Trending